Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 2
1901 2
1902 1
1903 1
1906 1
1908 1
1915 1
1916 1
1925 1
1936 1
1942 1
1946 4
1947 3
1948 5
1949 8
1950 8
1951 11
1952 6
1953 3
1954 5
1955 1
1956 1
1957 2
1958 7
1959 4
1960 4
1961 11
1962 8
1963 6
1964 5
1965 9
1966 6
1967 7
1968 14
1969 7
1970 7
1971 11
1972 11
1973 13
1974 8
1975 5
1976 10
1977 7
1978 11
1979 16
1980 8
1981 13
1982 11
1983 23
1984 16
1985 22
1986 22
1987 20
1988 24
1989 21
1990 17
1991 21
1992 18
1993 21
1994 10
1995 10
1996 11
1997 25
1998 16
1999 15
2000 9
2001 9
2002 11
2003 16
2004 9
2005 15
2006 12
2007 16
2008 17
2009 23
2010 15
2011 18
2012 14
2013 25
2014 28
2015 32
2016 27
2017 43
2018 25
2019 33
2020 32
2021 56
2022 44
2023 64
2024 44
2025 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,193 results

Results by year

Filters applied: . Clear all
Page 1
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Strickler JH, Cercek A, Siena S, André T, Ng K, Van Cutsem E, Wu C, Paulson AS, Hubbard JM, Coveler AL, Fountzilas C, Kardosh A, Kasi PM, Lenz HJ, Ciombor KK, Elez E, Bajor DL, Cremolini C, Sanchez F, Stecher M, Feng W, Bekaii-Saab TS; MOUNTAINEER investigators. Strickler JH, et al. Among authors: hubbard jm. Lancet Oncol. 2023 May;24(5):496-508. doi: 10.1016/S1470-2045(23)00150-X. Lancet Oncol. 2023. PMID: 37142372 Clinical Trial.
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Hecht JR, Hoffe S, Hubbard J, Hunt S, Hussan H, Jeck W, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Maratt J, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stotsky-Himelfarb E, Tavakkoli A, Willett CG, Williams G, Algieri F, Gurski L, Stehman K. Benson AB, et al. Among authors: hubbard j. J Natl Compr Canc Netw. 2023 Jun;21(6):653-677. doi: 10.6004/jnccn.2023.0030. J Natl Compr Canc Netw. 2023. PMID: 37308125
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines.
Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S, Line PD, Adam R. Bonney GK, et al. Among authors: hubbard j. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):933-946. doi: 10.1016/S2468-1253(21)00219-3. Epub 2021 Sep 8. Lancet Gastroenterol Hepatol. 2021. PMID: 34506756
Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies.
Di Marco T, Djonlagic I, Dauvilliers Y, Sadeghi K, Little D, Datta AN, Hubbard J, Hajak G, Krystal A, Olivieri A, Parrino L, Puryear CB, Zammit G, Donoghue J, Scammell TE. Di Marco T, et al. Among authors: hubbard j. Sleep. 2024 Nov 8;47(11):zsae098. doi: 10.1093/sleep/zsae098. Sleep. 2024. PMID: 38644625 Free PMC article. Clinical Trial.
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.
Seth NP, Xu R, DuPrie M, Choudhury A, Sihapong S, Tyler S, Meador J, Avery W, Cochran E, Daly T, Brown J, Rutitzky L, Markowitz L, Kumar S, Beavers T, Bhattacharya S, Chen H, Parge V, Price K, Wang Y, Sukumaran S, Pao Y, Abouzahr K, Elwood F, Duffner J, Roy S, Narayanaswami P, Hubbard JJ, Ling LE. Seth NP, et al. Among authors: hubbard jj. MAbs. 2025 Dec;17(1):2461191. doi: 10.1080/19420862.2025.2461191. Epub 2025 Feb 12. MAbs. 2025. PMID: 39936406 Free PMC article.
Racism in Drug Testing.
Hubbard JA, Johnson-Davis KL. Hubbard JA, et al. Clin Lab Med. 2024 Dec;44(4):607-617. doi: 10.1016/j.cll.2024.07.006. Epub 2024 Sep 20. Clin Lab Med. 2024. PMID: 39490119 Review.
1,193 results